J. L. Kambou

Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.

Sarah A. Meyer, Ryan T Novak, B. Flannery, 2012, MMWR. Morbidity and mortality weekly report.

Grand Rounds : The Million Hearts Initiative

Madison, Ryan T Novak, Atlanta, 2012 .

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso

B. Gessner, P. Jaillard, B. Njanpop-Lafourcade, 2011, PloS one.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Ryan T Novak, L. Mayer, T. Clark, 2012, The Lancet. Infectious diseases.

Neisseria meningitidis Serogroup W, Burkina Faso, 2012

Ryan T Novak, L. Mayer, T. Clark, 2014, Emerging infectious diseases.

Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

Michael L. Jackson, Isaïe Medah, Ryan T Novak, 2013, PloS one.

Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness.

K. Wannemuehler, A. Uzicanin, J. Goodson, 2012, Vaccine.

Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.

Sarah A. Meyer, Ryan T Novak, K. Wannemuehler, 2015, Vaccine.